Interleukin-26, preferentially produced by TH17 lymphocytes, regulates CNS barrier function
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 18, 2020
- Accepted in final form July 13, 2020
- First Published August 11, 2020.
Author Disclosures
- Bieke Broux, PhD*,
- Stephanie Zandee, PhD*,
- Elizabeth Gowing, MSc,
- Marc Charabati, MSc,
- Marc-André Lécuyer, PhD,
- Olivier Tastet, MSc,
- Lamia Hachehouche, MSc,
- Lyne Bourbonnière, MSc,
- Jean-Philippe Ouimet, MSc,
- Florent Lemaitre, MSc,
- Sandra Larouche, DCS,
- Romain Cayrol, MD, PhD, FRCPC,
- Alain Bouthillier, MD, FRCSC,
- Robert Moumdjian, MD, FRCSC,
- Boaz Lahav, BSc,
- Josée Poirier, BSc,
- Pierre Duquette, MD, FRCPC,
- Nathalie Arbour, PhD,
- Evelyn Peelen, PhD‡ and
- Alexandre Prat, MD, PhD, FRCPC‡
- Bieke Broux, PhD*,
NONE
NONE
NONE
(1) Frontiers in Immunology, Research Topic editor, 2019
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) FWO Flanders, 1506518N, PI, 2018
NONE
(1) Stichting MS Research - Global MS Research Booster Award (2) Charcot Stichting - Project (3) ECTRIMS - Postdoctoral Research Fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Stephanie Zandee, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1 Multiple Sclerosis Society of Canada (MSSC) 2 Fonds de recherche du Québec - Santé (FRQS)
NONE
NONE
NONE
NONE
NONE
NONE
- Elizabeth Gowing, MSc,
NONE
NONE
(1)Multiple Sclerosis Society of Canada, cheque compensation for travel (2)Americas Committee for Treatment and Research In Multiple Sclerosis, cheque compensation for travel
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Fonds de recherche du Quebec-Sante, doctoral scholarship, 2016-2020
NONE
Multiple Sclerosis Society of Canada, doctoral scholarship, 2016-2021
NONE
NONE
NONE
NONE
NONE
NONE
- Marc Charabati, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marc-André Lécuyer, PhD,
NONE
NONE
(1) MS Society of Canada - Travel award(2) German Society for Immunology - Travel award(3) International Society of Neuroimmunology - Travel award(4) European Society of Neuroimmunology - Travel award
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) DFG, German Research Fundation, 2019-(2) FRQS, Post-Doctoral Fellowship, 2016-2019(3) FRQS, Doctoral Training Award, 2012-2015
NONE
(1) MS Society of Canada, Post-Doctoral Fellowship, 2016-2019
NONE
NONE
NONE
NONE
NONE
NONE
- Olivier Tastet, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lamia Hachehouche, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lyne Bourbonnière, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jean-Philippe Ouimet, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Florent Lemaitre, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sandra Larouche, DCS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Romain Cayrol, MD, PhD, FRCPC,
NONE
NONE
NONE
NONE
Modulation of MCAM in neuroinflammation US Patents # 8293468 and 9017682
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
US Patent, University licensing office, 4 years
NONE
NONE
NONE
- Alain Bouthillier, MD, FRCSC,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Moumdjian, MD, FRCSC,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Boaz Lahav, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Josée Poirier, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pierre Duquette, MD, FRCPC,
Member of advisory boards for Biogen-Idec, EMD Serono, Novartis, TEVANeuroscience, Genzyme.
NONE
NONE
NONE
Shared patent for a cellular adhesion molecule.
NONE
NONE
NONE
NONE
Organisation of CME activities with Biogen-Idec, EMD Serono, Novartis, TEVANeuroscience, Genzyme.
NONE
Investigator-initiated study funded by Biogen-Idec, by Novartis,EMD Serono, and by Genzyme.
CIHR grant (co-investigator). MS Society of Canada (co-investigator).
MS Society of Canada.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nathalie Arbour, PhD,
NONE
NONE
NONE
Editoral Board for Multiple Sclerosis Journal NO compensation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Canadian Institutes of Health Research- 2014-2019 Natural Sciences and Engineering Research Council-2019-2024
Research Chair Neurosurgery-Université de Montreal- 2019- 2024
Multiple Sclerosis SOciety of Canada 2017-2020
NONE
NONE
NONE
NONE
NONE
NONE
- Evelyn Peelen, PhD‡ and
NONE
NONE
NONE
NONE
NONE
NONE
Immunic AG, Scientist, 9 months
NONE
NONE
NONE
NONE
NONE
The Fonds de la recherche en santé du Québec (FRQS; Canada), Postoctoral Fellowship for candidates non-resident in Quebec, 2016-2017 FRQS/MSSC (Multiple Sclerosis Society of Canada) Partnership Award, Postoctoral Fellowship, 2017-2019
NONE
FRQS/MSSC (Multiple Sclerosis Society of Canada) Partnership Award, Postoctoral Fellowship, 2017-2019
NONE
NONE
NONE
NONE
NONE
NONE
- Alexandre Prat, MD, PhD, FRCPC‡
Biogen, EMD Serono, Teva, Celgene
NONE
NONE
(1) Multiple Sclerosis Journal, associate editor; (2) Cellular Immunology, associate editor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Neuroimmunology Unit and Multiple Sclerosis Clinic (B.B., S.Z., E.G., M.C., M.-A.L., O.T., L.H., L.B., J.-P.O., F.L., S.L., R.C., B.L., J.P., P.D., N.A., E.P., A.P.), The Research Center of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Department of Neuroscience, Faculty of Medicine, Université de Montréal, Canada; Hasselt University (B.B.), Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium; and Division of Neurosurgery (A.B., R.M.), Centre Hospitalier de l'Université de Montréal (CHUM), Faculty of Medicine, Université de Montréal, Canada.
- Correspondence
Dr. Prat a.prat{at}umontreal.ca
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Views & Reviews
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiologyKazuo Fujihara, Jeffrey L. Bennett, Jerome de Seze et al.Neurology: Neuroimmunology & Neuroinflammation, August 20, 2020 -
Article
Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAECyril Laurent, Gabrielle Deblois, Marie-Laure Clénet et al.Neurology: Neuroimmunology & Neuroinflammation, December 15, 2020 -
Article
Dimethyl fumarate suppresses granulocyte macrophage colony-stimulating factor–producing Th1 cells in CNS neuroinflammationFarinaz Safavi, Rodolfo Thome, Zichen Li et al.Neurology: Neuroimmunology & Neuroinflammation, May 05, 2020 -
Views & Reviews
Interferon beta in the treatment of multiple sclerosisMechanisms of actionV. Wee Yong, Sophie Chabot, Olaf Stuve et al.Neurology, September 01, 1998